BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8854893)

  • 21. Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: role of mesencephalic glia.
    Engele J; Schubert D; Bohn MC
    J Neurosci Res; 1991 Oct; 30(2):359-71. PubMed ID: 1686785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
    Strömberg I; Björklund L; Johansson M; Tomac A; Collins F; Olson L; Hoffer B; Humpel C
    Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M; Cutillas B; Arenas TE; Ambrosio S
    Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurturin enhances the survival of axotomized retinal ganglion cells in vivo: combined effects with glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor.
    Koeberle PD; Ball AK
    Neuroscience; 2002; 110(3):555-67. PubMed ID: 11906793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secretion of GDNF by glial cells does not account for the neurotrophic effect of bFGF on dopamine neurons in vitro.
    Hou JG; Mytilineou C
    Brain Res; 1996 Jun; 724(1):145-8. PubMed ID: 8816270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity.
    Mena MA; Casarejos MJ; García de Yébenes J
    J Neural Transm (Vienna); 1999; 106(11-12):1105-23. PubMed ID: 10651107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM
    Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone mesenchymal stromal cells stimulate neurite outgrowth of spinal neurons by secreting neurotrophic factors.
    Gu W; Zhang F; Xue Q; Ma Z; Lu P; Yu B
    Neurol Res; 2012 Mar; 34(2):172-80. PubMed ID: 22333032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
    Lu X; Hagg T
    J Comp Neurol; 1997 Nov; 388(3):484-94. PubMed ID: 9368855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
    Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.
    Bowenkamp KE; Hoffman AF; Gerhardt GA; Henry MA; Biddle PT; Hoffer BJ; Granholm AC
    J Comp Neurol; 1995 May; 355(4):479-89. PubMed ID: 7636027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage.
    Pérez-Navarro E; Arenas E; Reiriz J; Calvo N; Alberch J
    Neuroscience; 1996 Nov; 75(2):345-52. PubMed ID: 8931001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The survival response of mesencephalic dopaminergic neurons to the neurotrophins BDNF and NT-4 requires priming with serum: comparison with members of the TGF-beta superfamily and characterization of the serum-free culture system.
    Krieglstein K; Maysinger D; Unsicker K
    J Neural Transm Suppl; 1996; 47():247-58. PubMed ID: 8841970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment.
    Zhou J; Bradford HF; Stern GM
    Brain Res; 1994 Sep; 656(1):147-56. PubMed ID: 7804829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin.
    Rosenblad C; Grønborg M; Hansen C; Blom N; Meyer M; Johansen J; Dagø L; Kirik D; Patel UA; Lundberg C; Trono D; Björklund A; Johansen TE
    Mol Cell Neurosci; 2000 Feb; 15(2):199-214. PubMed ID: 10673327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfection of C6 glioma cells with glia maturation factor upregulates brain-derived neurotrophic factor and nerve growth factor: trophic effects and protection against ethanol toxicity in cerebellar granule cells.
    Pantazis NJ; Zaheer A; Dai D; Zaheer S; Green SH; Lim R
    Brain Res; 2000 May; 865(1):59-76. PubMed ID: 10814733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.
    Sautter J; Tseng JL; Braguglia D; Aebischer P; Spenger C; Seiler RW; Widmer HR; Zurn AD
    Exp Neurol; 1998 Jan; 149(1):230-6. PubMed ID: 9454632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotrophic function of conditioned medium from human amniotic epithelial cells.
    Uchida S; Inanaga Y; Kobayashi M; Hurukawa S; Araie M; Sakuragawa N
    J Neurosci Res; 2000 Nov; 62(4):585-90. PubMed ID: 11070502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of neurotrophic factors GDNF and NT-3, but not BDNF, with the immune system following fetal spinal cord transplantation.
    Shinoda M; Hoffer BJ; Olson L
    Brain Res; 1996 May; 722(1-2):153-67. PubMed ID: 8813361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minor immunoreactivity in GDNF-, BDNF-, or NT-3-treated substantia nigra allografts.
    Shinoda M; Hoffer BJ; Olson L
    J Neural Transplant Plast; 1997; 6(2):83-96. PubMed ID: 9306240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.